Details
Stereochemistry | RACEMIC |
Molecular Formula | C34H38N3O7P.C2H6O.ClH |
Molecular Weight | 714.185 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCO.CC1=C(C(C2=CC=CC(=C2)[N+]([O-])=O)C(=C(C)N1)P3(=O)OCC(C)(C)CO3)C(=O)OCCN(CC4=CC=CC=C4)C5=CC=CC=C5
InChI
InChIKey=IKBJGZQVVVXCEQ-UHFFFAOYSA-N
InChI=1S/C34H38N3O7P.C2H6O.ClH/c1-24-30(33(38)42-19-18-36(28-15-9-6-10-16-28)21-26-12-7-5-8-13-26)31(27-14-11-17-29(20-27)37(39)40)32(25(2)35-24)45(41)43-22-34(3,4)23-44-45;1-2-3;/h5-17,20,31,35H,18-19,21-23H2,1-4H3;3H,2H2,1H3;1H
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/12070536
Sources: http://www.ncbi.nlm.nih.gov/pubmed/12070536
Efonidipine is a 1,4-dihydropyridine derivative for the treatment of hypertension and angina. Efonidipine exerts its antihypertensive and antianginal effects through blocking L- and T-type calcium channels.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2362995 Sources: http://www.ncbi.nlm.nih.gov/pubmed/12070536 |
13.0 nM [IC50] | ||
Target ID: CHEMBL2095229 Sources: http://www.ncbi.nlm.nih.gov/pubmed/12070536 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | LANDEL Approved UseUnknown |
|||
Primary | LANDEL Approved UseUnknown |
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/24944418
40 mg once daily for 12 weeks
Route of Administration:
Oral
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/8723524
Effects of efonidipine on isolated myocardial and aortic preparations was studied. The drug produced concentration-dependent negative chronotropic effects on isolated guinea-pig atrial preparations.The potency was 3.08 x 10(-8)M (EC30).
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000085033
Created by
admin on Sat Dec 16 05:42:23 GMT 2023 , Edited by admin on Sat Dec 16 05:42:23 GMT 2023
|
PRIMARY | |||
|
SUB21684
Created by
admin on Sat Dec 16 05:42:23 GMT 2023 , Edited by admin on Sat Dec 16 05:42:23 GMT 2023
|
PRIMARY | |||
|
163838
Created by
admin on Sat Dec 16 05:42:23 GMT 2023 , Edited by admin on Sat Dec 16 05:42:23 GMT 2023
|
PRIMARY | |||
|
DTXSID5020150
Created by
admin on Sat Dec 16 05:42:23 GMT 2023 , Edited by admin on Sat Dec 16 05:42:23 GMT 2023
|
PRIMARY | |||
|
135859
Created by
admin on Sat Dec 16 05:42:23 GMT 2023 , Edited by admin on Sat Dec 16 05:42:23 GMT 2023
|
PRIMARY | |||
|
84HJ0Q6TMN
Created by
admin on Sat Dec 16 05:42:23 GMT 2023 , Edited by admin on Sat Dec 16 05:42:23 GMT 2023
|
PRIMARY | |||
|
111011-76-8
Created by
admin on Sat Dec 16 05:42:23 GMT 2023 , Edited by admin on Sat Dec 16 05:42:23 GMT 2023
|
PRIMARY | |||
|
m4841
Created by
admin on Sat Dec 16 05:42:23 GMT 2023 , Edited by admin on Sat Dec 16 05:42:23 GMT 2023
|
PRIMARY | Merck Index |
ACTIVE MOIETY
SUBSTANCE RECORD